Restricted accessResearch articleFirst published online 2016-03
ORF3 of Hepatitis E Virus Inhibits the Expression of Proinflammatory Cytokines and Chemotactic Factors in LPS-Stimulated Human PMA-THP1 Cells by Inhibiting NF-κB Pathway
Hepatitis E virus (HEV) is one of the primary causative agents of acute hepatitis. It is noteworthy that HEV can develop chronic infection and even lead to liver cirrhosis; however, the mechanism has not been revealed. In this study, the ELISA assay was used to detect protein levels, and we found that HEV open reading frame 3 (ORF3) protein inhibited the expression of proinflammatory cytokines (tumor necrosis factor-alpha [TNF-α], interleukin [IL]-1β, IL-6, IL-8, IL-12p40, and IL-18) and chemotactic factors (nitric oxide [NO], interferon-inducible protein-10 (IP-10), macrophage inflammatory protein (MIP)-1α, monocyte chemoattractant protein-1 (MCP-1), granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF)] in lipopolysaccharide (LPS)-stimulated human PMA-THP1 cells. Further study showed that mRNA and protein levels of pattern recognition receptors (PRRs), such as Toll-like receptor 4 (TLR4), TNF receptor-associated factor 6 (TRAF6), and nucleotide-binding oligomerization domain containing 2 (NOD2), decreased after infection of pLL3.7-ORF3 (pORF3); moreover, the inhibition produced corresponding upregulation of IκBα and downregulation of phosphorylated IκB kinase IKKɛ (p-IKKɛ) and phosphorylated nuclear factor (NF)-κB (p-NF-κB), but little variation was found in the concentration of IKKɛ and NF-κB. Taken together, our results demonstrated that HEV ORF3 attenuated LPS-induced cytokine production and chemotactic factors, predominantly by inhibiting various PRRs-mediated NF-κB signaling pathways. The anti-inflammatory properties might be of great importance to clarify the role and mechanism of macrophages in chronic HEV infection and cirrhosis.
Get full access to this article
View all access options for this article.
References
1.
AdliM, and BaldwinAS. IKK-i/IKKepsilon controls constitutive, cancer cell-associated NF-kappaB activity via regulation of Ser-536 p65/RelA phosphorylation. J Biol Chem, 2006; 281:26976–26984.
2.
AggarwalBB. Nuclear factor-kappa-B: the enemy within. Cancer Cell, 2004; 6:203–208.
3.
AhmadI, HollaRP, and JameelS. Molecular virology of hepatitis E virus. Virus Res, 2011; 161:47–58.
4.
AkiraS, and HemmiH. Recognition of pathogen-associated molecular patterns by TLR family. Immunol Lett, 2003; 85:85–95.
5.
AkiraS, TakedaK, and KaishoT. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol, 2001; 2:675–680.
6.
ChandraV, TanejaS, KaliaM, et al.Molecular biology and pathogenesis of hepatitis E virus. J Biosci, 2008; 33:451–464.
7.
ChoiEK, KimSY, KimSH, et al.Proteolytic activity of Porphyromonas gingivalis attenuates MCP-1 mRNA expression in LPS-stimulated THP-1 cells. Microb Pathog, 2014; 73:13–18.
8.
ChungYH, JhunBH, RyuSC, et al.STP-C, an oncoprotein of herpesvirus saimiri augments the activation of NF-kappa B through ubiquitination of TRAF6. J Biochem Mol Biol, 2007; 40:341–348.
9.
DongC, ZafrullahM, Mixson-HaydenT, et al.Suppression of interferon-alpha signaling by hepatitis E virus. Hepatology, 2012; 55:1324–1332.
10.
FaheyS, DempseyE, and LongA. The role of chemokines in acute and chronic hepatitis C infection. Cell Mol Immunol, 2014; 11:25–40.
11.
GengYS, ZhaoCY, FanJP, et al.Genotype analysis of hepatitis E virus from sporadic hepatitis E cases in northern China. Infect Genet Evol, 2013; 20:413–417.
12.
Gonzalez TallonAI, Moreira VicenteV, Mateos LindemannML, et al.[Chronic hepatitis E in an immunocompetent patient]. Gastroenterol Hepatol, 2011; 34:398–400.
13.
GraffJ, NguyenH, YuC, et al.The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaques. J Virol, 2005; 79:6680–6689.
14.
GrewalP, KamiliS, and MotamedD. Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology, 2014; 59:347–348.
15.
HarrisJ, OliereS, SharmaS, et al.Nuclear Accumulation of cRel following C-Terminal phosphorylation by TBK1/IKK. J Immunol, 2006; 177:2527–2535.
16.
HemmiH, TakeuchiO, SatoS, et al.The roles of two I kappa B kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J Exp Med, 2004; 199:1641–1650.
17.
HollaRP, AhmadI, AhmadZ, et al.Molecular virology of hepatitis E virus. Semin Liver Dis, 2013; 33:3–14.
18.
HsiehCS, MacatoniaSE, TrippCS, et al.Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science, 1993; 260:547–549.
19.
InoharaN, KosekiT, LinJM, et al.An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J Biol Chem, 2000; 275:27823–27831.
20.
JeonDI, ParkSR, AhnMY, et al.NOD1 and NOD2 stimulation triggers innate immune responses of human periodontal ligament cells. Int J Mol Med, 2012; 29:699–703.
21.
JeongE, and LeeJY. Intrinsic and extrinsic regulation of innate immune receptors. Yonsei Med J, 2011; 52:379–392.
22.
JeongS, ChoIR, AnWG, et al.STP-A11, an oncoprotein of Herpesvirus saimiri augments both NF-kappa B and AP-1 transcription activity through TRAF6. Exp Mol Med, 2007; 39:56–64.
23.
LeeMS, and MinYJ. Signaling pathways downstream of pattern-recognition receptors and their cross talk. Annu Rev Biochem, 2007; 76:447–480.
24.
LiuD, WuA, CuiL, et al.Hepatitis B virus polymerase suppresses NF-kappaB signaling by inhibiting the activity of IKKs via interaction with Hsp90beta. PLoS One, 2014; 9:e91658.
25.
LiuQL, QianY, ChenF, et al.EGCG attenuates pro-inflammatory cytokines and chemokines production in LPS-stimulated L02 hepatocyte. Acta Biochim Biophys Sin (Shanghai), 2014; 46:31–39.
26.
MarraF, and TackeF. Roles for chemokines in liver disease. Gastroenterology, 2014; 147:577–594.
27.
McWhirterSM, FitzgeraldKA, RosainsJ, et al.IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc Natl Acad Sci U S A, 2004; 101:233–238.
MoinSM, PantevaM, and JameelS. The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death. J Biol Chem, 2007; 282:21124–21133.
30.
MotteA, RoquelaureB, GalambrunC, et al.Hepatitis E in three immunocompromized children in southeastern France. J Clin Virol, 2012; 53:162–166.
31.
MurakamiK, SuzukiC, KobayashiF, et al.Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways. Naunyn Schmiedeberg Arch Pharmacol, 2012; 385:891–898.
32.
PoltorakA, HeX, SmirnovaI, et al.Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science, 1998; 282:2085–2088.
33.
RoyAK, KorkayaH, OberoiR, et al.The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphatase. J Biol Chem, 2004; 279:28345–28357.
34.
SharmaS, tenOeverBR, GrandvauxN, et al.Triggering the interferon antiviral response through an IKK-related pathway. Science, 2003; 300:1148–1151.
35.
TangYZ, YanF, PanKC, et al.[Hepatitis B e antigen perturbs the LPS-stimulated production of inflammatory cytokines by mononuclear-derived dendritic cells]. Zhonghua Gan Zang Bing Za Zhi, 2013; 21:590–593.
36.
ViolaA, and LusterAD. Chemokines and their receptors: drug targets in immunity and inflammation. Annu Rev Pharmacol Toxicol, 2008; 48:171–197.
37.
WaggonerSN, CruiseMW, KasselR, et al.gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway. J Immunol, 2007; 178:3332–3332.
38.
WangJ, ZhangJ, and TianD. Open reading frame 3 protein of hepatitis E virus suppresses TNF-α-mediated NF-κB activation in hepatocyte. Chin J Integr Tradit West Med Liver Dis, 2012; 22:30–31, 50–51.
39.
XuJ, WuF, TianD, et al.Open reading frame 3 of genotype 1 hepatitis E virus inhibits nuclear factor-kappa B signaling induced by tumor necrosis factor-α in human A549 lung epithelial cells. PLoS One, 2014; 9:e100787.
YoonYK, WooHJ, and KimY. Orostachys japonicus inhibits expression of the TLR4, NOD2, iNOS, and COX-2 genes in LPS-stimulated human PMA-differentiated THP-1 cells by inhibiting NF-kappa B and MAPK activation. Evid Based Complement Alternat Med, 2015; 2015:682019.
42.
ZhangJZ, and WardKW. Besifloxacin, a novel fluoroquinolone antimicrobial agent, exhibits potent inhibition of pro-inflammatory cytokines in human THP-1 monocytes. J Antimicrob Chemother, 2008; 61:111–116.
